Is Surgery Necessary for Femoral Insufficiency Fractures after Long-term Bisphosphonate Therapy?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Prolonged use of bisphosphonates in patients with osteoporosis reportedly induces femoral insufficiency fractures. However, the natural course of these fractures and how to treat them remain unknown.
We determined the rates of fracture displacement and subsequent operations of undisplaced insufficiency fractures of the femur in patients treated with prolonged bisphosphonate therapy.
Patients and Methods
We retrospectively collected and reviewed the clinical course of 11 patients (14 fractures) who had been diagnosed as having an insufficiency fracture of the femur after prolonged use (mean, 4.5 years; range, 3–10 years) of bisphosphonate. All patients were women with a mean age of 68 years (range, 57–82 years). The fracture site was subtrochanteric in six and femoral shaft in eight. The minimum followup was 12 months (mean, 27 months; range, 12–60 months).
During the followup period, secondary displacement of the fracture occurred in five of the 14 fractures after a mean of 10 months (range, 1–19 months). Three fractures were treated with internal fixation using a compression hip screw and two with intramedullary nailing. Because five additional fractures were treated surgically owing to intractable pain, surgery was performed in 10 of 14 insufficiency fractures during the followup period. All 10 fractures healed during followup. The remaining four patients (four fractures) not undergoing any surgery had persistent pain.
Femoral insufficiency fractures after prolonged bisphosphonate therapy seldom healed spontaneously and most patients had surgery either for fracture displacement or persistent pain.
Level of Evidence
Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
- Allen, MR, Iwata, K, Phipps, R, Burr, DB (2006) Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone. 39: pp. 872-879 CrossRef
- Black, DM, Kelly, MP, Genant, HK, Palermo, L, Eastell, R, Bucci-Rechtweg, C, Cauley, J, Leung, PC, Boonen, S, Santora, A, Papp, A, Bauer, DC (2010) Fracture Intervention Trial Steering Committee; HORIZON Pivotal Fracture Trial Steering Committee. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 362: pp. 1761-1771 CrossRef
- Boden, BP, Osbahr, DC, Jimenez, C (2001) Low-risk stress fractures. Am J Sports Med. 29: pp. 100-111
- Boivin, GY, Chavassieux, PM, Santora, AC, Yates, J, Meunier, PJ (2000) Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 27: pp. 687-694 CrossRef
- Bone, HG, Hosking, D, Devogelaer, JP, Tucci, JR, Emkey, RD, Tonino, RP, Rodriguez-Portales, JA, Downs, RW, Gupta, J, Santora, AC, Liberman, UA (2004) Alendronate Phase III Osteoporosis Treatment Study Group. Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med. 350: pp. 1189-1199 CrossRef
- Capeci, CM, Tejwani, NC (2009) Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 91: pp. 2556-2561 CrossRef
- Eastell, R, Barton, I, Hannon, RA, Chines, A, Garnero, P, Delmas, PD (2003) Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res. 18: pp. 1051-1056 CrossRef
- Frolke, JP, Patka, P (2007) Definition and classification of fracture non-unions. Injury 38: pp. S19-S22 CrossRef
- Goh, SK, Yang, KY, Koh, JS, Wong, MK, Chua, SY, Chua, DT, Howe, TS (2007) Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 89: pp. 349-353 CrossRef
- Heckman, JD, Ryaby, JP, McCabe, J, Frey, JJ, Kilcoyne, RF (1994) Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound. J Bone Joint Surg Am. 76: pp. 26-34
- Iwamoto, J, Takeda, T (2002) Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report. J Orthop Sci. 7: pp. 707-712 CrossRef
- Kanis, JA, Melton, LJ, Christiansen, C, Johnston, CC, Khaltaev, N (1994) The diagnosis of osteoporosis. J Bone Miner Res. 9: pp. 1137-1141 CrossRef
- Komatsubara, S, Mori, S, Mashiba, T, Ito, M, Li, J, Kaji, Y, Akiyama, T, Miyamoto, K, Cao, Y, Kawanishi, J, Norimatsu, H (2003) Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res. 18: pp. 512-520 CrossRef
- Komatsubara, S, Mori, S, Mashiba, T, Li, J, Nonaka, K, Kaji, Y, Akiyama, T, Miyamoto, K, Cao, Y, Kawanishi, J, Norimatsu, H (2004) Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. J Bone Miner Res. 19: pp. 999-1005 CrossRef
- Kwek, EB, Goh, SK, Koh, JS, Png, MA, Howe, TS (2008) An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?. Injury 39: pp. 224-231 CrossRef
- Mashiba, T, Hirano, T, Turner, CH, Forwood, MR, Johnston, CC, Burr, DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 15: pp. 613-620 CrossRef
- Mashiba, T, Turner, CH, Hirano, T, Forwood, MR, Johnston, CC, Burr, DB (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone. 28: pp. 524-531 CrossRef
- Neviaser, AS, Lane, JM, Lenart, BA, Edobor-Osula, F, Lorich, DG (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 22: pp. 346-350 CrossRef
- Niimi, R, Hasegawa, M, Sudo, A, Uchida, A (2008) Unilateral stress fracture of the femoral shaft combined with contralateral insufficiency fracture of the femoral shaft after bilateral total knee arthroplasty. J Orthop Sci. 13: pp. 572-575 CrossRef
- Odvina, CV, Zerwekh, JE, Rao, DS, Maalouf, N, Gottschalk, FA, Pak, CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 90: pp. 1294-1301 CrossRef
- Sayed-Noor, AS, Sjoden, GO (2009) Case reports: two femoral insufficiency fractures after long-term alendronate therapy. Clin Orthop Relat Res. 467: pp. 1921-1926 CrossRef
- Stepan, JJ, Burr, DB, Pavo, I, Sipos, A, Michalska, D, Li, J, Fahrleitner-Pammer, A, Petto, H, Westmore, M, Michalsky, D, Sato, M, Dobnig, H (2007) Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone. 41: pp. 378-385 CrossRef
- Visekruna, M, Wilson, D, McKiernan, FE (2008) Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab. 93: pp. 2948-2952 CrossRef
- Is Surgery Necessary for Femoral Insufficiency Fractures after Long-term Bisphosphonate Therapy?
Clinical Orthopaedics and Related Research®
Volume 468, Issue 12 , pp 3393-3398
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul, South Korea
- 2. Department of Orthopaedic Surgery, Daegu Catholic University College of Medicine, Daegu, South Korea
- 3. Department of Orthopaedic Surgery, Chung General Hospital, Seongnam, South Korea
- 4. Department of Orthopaedic Surgery, Kyungpook National University College of Medicine, Daegu, South Korea
- 5. Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam, 463-707, South Korea